Latest filing published 17 May 2024 for Algernon Pharmaceuticals Inc., €1,940.
Christopher Scott Bryan is a declared insider of Algernon Pharmaceuticals Inc., with filings sourced from SEDI. In total, 6 filings cover trades dated from 1 March 2021 to 17 May 2024.
On the market, this insider has only ever bought: 5 purchases, €6,752 in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2024 alone, the filings show 5 purchases and no sales.
In size, the median ticket on the buying side is €1,559. None of the 5 purchases we analysed coincided with buying by another insider of the same company within 30 days.
The newest entry dates from 17 May 2024: an open-market purchase of €1,940, in Algernon Pharmaceuticals Inc. Between a trade and the moment it shows up on SEDI, the median delay is 2 days. That lag is the time during which only the insider knows about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations